¶àÄÒÂѳ²×ÛºÏÕ÷£¨polycystic ovarian syndrome, pCOS£©ÊÇÒ»ÖÖ³£¼ûµÄÉúÖ³¹¦ÄÜÕϰ­Óë´úлÒì³£²¢´æµÄÄÚ·ÖÃÚÎÉÂÒ×ÛºÏÕ÷£¬ÔÚÊÀ½ç·¶Î§ÄÚÓýÁ举ŮÖз¢²¡ÂÊÔ¼10%-20%£¬µ«»úÖÆÉÐδÃ÷È·¡£pCOS·¢Éú·¢Õ¹Óë»·¾³ÎÛȾÎïÃÜÇÐÏà¹Ø£¬Ñо¿ÄÚ·ÖÃÚ¸ÉÈÅÎendocrine disrupting chemicals, EDCs£©ÓÕ·¢pCOSµÄ¹ý³Ì¡¢Ð§Ó¦¡¢ãÐÖµ¼°»úÖÆ£¬¶ÔÓÚÎÛȾÎï¿ØÖÆ¡¢¶¾ÐÔ»úÖÆÀí½âÒÔ¼°pCOS¼²²¡µÄ¸ÉÔ¤ºÍÖÎÁƵȷ½Ãæ¾ßÓÐÖØÒª¿ÆÑ§ÒâÒåºÍÉç»á¼ÛÖµ¡£

ÂÑÅÝÊÇÅ®ÐÔÉúÖ³µÄ»ù±¾¹¦Äܵ¥Î»£¬ÓÉÉúֳϵÂÑĸϸ°ûºÍÂÑÅÝÌåϸ°û×é³É¡£Í¸Ã÷´øÊÇÒ»ÖÖµ°°×ÖÊ»ùÖÊ£¬Ëü½«ÂÑĸϸ°û´ÓÖÜΧµÄ³ÆÎª¿ÅÁ£Ï¸°û£¨granulosa cell£¬GC£©µÄÌåϸ°ûÖзÖÀë³öÀ´¡£Í¨¹ý¸»º¬¼¡¶¯µ°°×Ë¿£¨fibros actin, F-actin£©µÄα×ãÑù¿ç͸Ã÷´ø½á¹¹£¨transzonal projections, TZp£©ÓëÂÑĸϸ°û±£³Ö½Ó´¥¡£ÒòÂÑĸϸ°ûȱ·¦ÌǽͽâºÍµ¨¹Ì´¼´úл£¬ÆäÉú³¤·¢ÓýÒÀÀµÓÚ¿ÅÁ£Ï¸°û²úÉúµÄ´úл²úÎ²¢Í¨¹ýTZp×ªÒÆµ½ÂÑĸϸ°û¡£½üÈÕ£¬ÎÒÊÒ×óÕýºê½ÌÊÚ¼°ºÎ³ÐÓ¸±½ÌÊÚÑо¿ÍŶӡ¶Theranostics¡·ÉÏ·¢±íÂÛÎÄ£¬·¢ÏÖTZpµÄÆÆ»µ»áÓ°ÏìÂÑÅÝ·¢Óý£¬½ø¶øµ¼Ö¶àÄÒÂѳ²×ÛºÏÕ÷µÄ·¢Éú·¢Õ¹¡£

±¾Ñо¿Ê×ÏÈÓõäÐÍ»·¾³ÄÚ·ÖÃÚ¸ÉÈÅÎïÈý¶¡»ùÎý£¨tributyltin, TBT£©±©Â¶SD´óÊóÓÕµ¼pCOSÄ£ÐÍ£¬²¢ÓÃÌìÈ»¶à·Ó°×޼«´¼£¨resveratrol, RSV£©½øÐиÉÔ¤¡£Ñо¿·¢ÏÖTBT±©Â¶»áʹ´óÊóÌåÄڸƵ÷µ°°×¼¤Ã¸II¦Â£¨calcium-/calmodulin-dependent protein kinase II beta, CaMKII¦Â£©Ë®Æ½Éϵ÷£¬¹ý¶àµÄCaMKII¦Â»áÓëÇò×´¼¡¶¯µ°°×µ¥Ì壨globular actin, G-actin£©½áºÏ£¬Ê¹Æä²»ÄÜ˳ÀûºÏ³ÉF-actin£¬Ó°ÏìÂÑĸϸ°û-¿ÅÁ£Ï¸°û¼äË«ÏòͨѶ£¬ÂÑÅÝ·¢ÓýÊÜ×è´Ó¶øµ¼ÖÂpCOS¡£RSV¸ÉÔ¤¿ÉÒÔ¼¤»î¸ÆÀë×Óͨ·£¬Éϵ÷µÄ¸ÆÀë×ÓʹCaMKII¦ÂÁ×Ëữ²¢´ÓG-actinÉϽâÀëÏÂÀ´£¬Ê¹µÃ¼¡¶¯µ°°×µ¥Ìå¿ÉÒÔ¼ÌÐøºÏ³ÉF-actinÀ´ÐÞ¸´Ï¸°û¼äͨѶ¡£ÁíÍ⣬ͨ¹ý¸ßͨÁ¿»ùÒò±í´ïÊý¾Ý¿â£¨GEO£©·ÖÎö¼°ÁÙ´²Ñù±¾¼ì²â£¬·¢ÏÖÔÚÈËȺÖÐpCOS»¼ÕßµÄCAMK2B»ùÒò±í´ïˮƽ¸ßÓÚ½¡¿µÈËȺ£¬²¢ÇÒÆäÏËëºÏ³É¼°Ï¸°û¼äͨѶÏà¹ØÍ¨Â·ÊÜË𡣸ÃÑо¿·¢ÏÖ¹ý¶àCaMKII¦ÂÒÖÖÆTZpÐγɲÎÓëÁËpCOSµÄ²¡Àí¹ý³Ì£¬RSV¿É¼¤»îCaMKII¦ÂÒÔά³ÖTZpÕý³£ºÏ³É£¬Îª½«À´µÄpCOSÖÎÁÆÌṩÁËаеã¡£

ÎÒÊÒ×óÕýºê½ÌÊÚΪ¸ÃÎÄÕµÄͨѶ×÷Õߣ¬²©Ê¿Éú³ÂÃ÷ÔÂͬѧºÍºÎ³ÐÓ¸±½ÌÊÚΪ¸ÃÎÄÕµĹ²Í¬µÚÒ»×÷Õß¡£¸ÐлÏÃÃÅ´óѧ¸½Êô³É¹¦Ò½ÔºÉúÖ³ÖÐÐĽ¯ÏþÃ÷Ö÷ÈκͲ̼ÎÁ¦²©Ê¿µÄÖ§³Ö¡£±¾ÏîÄ¿µÃµ½¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ð£¨32071301£¬31971234£©£¬¸£½¨Ê¡×ÔÈ»¿ÆÑ§»ù½ð£¨2020J01027£©ºÍÖÐÑëÖØµãÏîÄ¿Ãû¹óÖÐÒ©×ÊÔ´¿É³ÖÐøÀûÓÃÄÜÁ¦½¨É裨2060302£©µÄÖ§³Ö¡£-

¸ÃÆÚµÄ·âÃæÎª¡°ÈµÇÅÏà»á¡±¡£ÖйúÉñ»°¹ÊÊÂÖеÄ֯ŮºÍÅ£ÀÉ·Ö±ð´ú±íÂÑĸϸ°ûºÍ¿ÅÁ£Ï¸°û£¬ÓÉÒøºÓ£¨Í¸Ã÷´ø£©¸ô¿ª¡£Ï²Èµ£¨G-actin£©´î³ÉȵÇÅ£¨TZp£©´Ó¶øÅ£ÀɺÍ֯ٵÃÒÔ½»Á÷£¬µ«ÊÇÍõĸÄïÄ´ú±íEDC£©Ç°À´ÆÆ»µ£¬ÍõĸÊÖÖеķ¨ÕÈÊͷųö¹â²¨Çò£¨CaMKII¦Â£©£¬ÔÒÖÐϲȵ²¢Ê¹Ï²Èµ×¹Â䣬ȵÇÅÎÞ·¨´î½¨³É¹¦£¬Å£ÀÉ֯ٴӴ˱»¸ô¿ª£¬ÂÑÅÝÎÞ·¨Õý³£·¢Óý´Ó¶øÒýÆðpCOS·¢Éú¡£

ÂÛÎÄÁ´½Ó£ºhttps://www.thno.org/v12p0782.htm

£¨Í¼/ÎÄ ×óÕýºê¿ÎÌâ×飩